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Affinity interactions can provide the very specific molecule identification which is 
needed for purification of important bio-molecules. Although many affinity bead gels 
are already commercially available for protein purification, the commonly used soft 
gels suffer from some drawbacks for large-scale applications. The performances of 
these gels is limited by low flow rate, weak compressibility and inevitable pore 
diffusion. The throughput of existing gel affinity systems has often been inadequate 
for quick large-scale separations.  
In recent years, micro-porous membranes have been successfully modified and 
various ligands have been coupled to the membrane surface for affinity 
chromatography purposes. Using membrane filtration with affinity ligands in free 
solution to bind and retain specific ligates has been demonstrated to be feasible. 
Although key factors governing the separation efficiency of these affinity systems are 
not yet clearly understood, many companies have put a lot of funding and energy into 
the affinity membrane purification industry and several products are available on the 
market now. (such as Sartobind
® 
Protein A membrane serials etc.) The primary aim of 
our research is to use regenerated cellulose nanofiber membranes, prepared by an 
electrospinning method, as affinity membranes for immunoglobulin G (IgG) 
purification. In this project, Protein A/G, which is genetically modified and 
specifically binds to IgG, was covalently coupled to the electrospun nanofiber 
membrane surface as a ligand to capture IgG molecules in free solution. Both the 
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physical and biological properties of our membrane were carefully characterized. The 
mechanical strength of our membrane was optimized by an Instron Microtester 5848. 
Surface element analysis was carried out to verify the immobilization of protein A/G. 
The amount of Protein A/G immobilized on the membrane was tested by the BCA 
method. The membrane binding capacity of IgG was evaluated using UV absorption 
measurement. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
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Chapter 1 Introduction 
1.1 Background 
Over the past few decades, the area of molecular biology and recombinant DNA 
technology has led to the rapid emergence of the genetic engineering industry. 
Genetic engineering made it possible to isolate and clone desired genes or DNA 
sequences in an appropriate host organism. It also enabled the reconstruction of genes 
which results in fusion proteins having combined properties of original gene products. 
The main application of gene fusion is recombinant protein purification, a technology 
pioneered by Uhlen and his collaborators in 1983 (Uhlen 1983).  
At this time, antibodies are the main products in gene engineering industry because 
they contribute much as biochemical tools in biotechnology and are used as 
therapeutics for the treatment of cancer and other diseases. Monoclonal antibodies 
(MAbs), which are mass produced in the laboratory from a single clone and 
recognizes only one antigen, are widely used in immunodiagnostic and therapeutic 
applications. Monoclonal antibodies are typically made by fusing a normally 
short-lived, antibody-producing B cell to a fast-growing cell, such as a cancer cell. 
[Figure 1.1] The emergence of novel applications for MAbs in therapeutic products, 
tumor imaging, and immuno-affinity separations suggests an exponential increase in 
their demand. Investment costs for commercial antibody production facilities are 







Figure 1.1 Monoclonal Antibody Productions  
Modified from www.accessexcellence.org/AB/GG/monoclonal.html 
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Although the large-scale production of these biopharmaceuticals and complex 
therapeutic proteins has been facilitated by advances in mammalian cell culture 
technology, the expressed antibodies in the culture medium of expression cell systems 
may contain many impurities. This raises the problem of antibody purification which 
is known to be a key stage in the preparation of biopharmaceuticals. Downstream 
processing, purification and polishing are of great importance to the antibody 
production. Clonis reports that 50–80% of the total manufacturing cost results from 
purification and polishing processes (Clonis 2006). Such high costs result from the 
stringent quality criteria imposed on protein products intended for human use (such as 
defined purity, efficacy, potency, stability, pharmacokinetics, pharmaco-dynamics, 
toxicity, and immunogenicity).  Unsurprisingly, the separation and analysis of 
monoclonal antibodies (MAbs) has therefore received much attention over the last 
decades.  
Several methods, each based on different principles [Figure 1.2] have be used for 
protein purification: gel filtration, ion exchange chromatography, high-resolution 
reversed-phase chromatography, hydrophobic interaction chromatography, etc. 
Among these methods, only affinity chromatography can separate or purify proteins 









Figure 1.2 Protein Purification Methods and Principles 






Table 1.1 Comparing Different Purification Methods 
Chosen for Different Levels of Protein Purification 
Cited from My Presentation PPT 
 
 
Affinity Chromatography (AC); Gel Filtration (GF); Ion Exchange Chromatography (IEX) 
The Three Levels of Protein Purification： 
Crude Protein：Cell lysis → get most of the protein 
Partially Purified：Protein isolation → get specific protein 




In affinity chromatography, functional component (ligand) immobilized on a support 
membrane is utilized to capture specific target molecules (ligate). In our project, the 
ligate is an antibody (immunoglobulin G, or IgG) and the ligand we use is protein 
A/G (developed by the Piece Company). This protein A/G is a genetically engineered, 
50,449 molecular weight protein that combines the IgG binding profiles of both 
Protein A and Protein G. It is a gene fusion product secreted from a nonpathogenic 
form of Bacillus. The secreted Protein A/G contains four Fc-binding domains from 
Protein A and two from Protein G [Figure 1.3] making it a more universal tool in the 
investigation and purification of immunoglobulins. Unlike non-recombinant Protein G, 
Protein A/G does not bind serum albumin because the gene sequence coding for the 
albumin-binding site has been eliminated. Protein A/G binds to all human IgG 
subclasses and it has a broader binding range than either Protein A or Protein G 
individually. Although IgG purification kits utilizing protein A or protein G 
individually are widely used in laboratory research, very few protein A/G utilizing 
kits are currently available for use.  
Ligand immobilized beads are the most frequently used affinity chromatography 
materials but this method suffers from drawbacks during large scale application in 
column chromatography. The performance of these gels is limited by their low 
loading flow rate, little compressibility and pore diffusion. In recent years, 
micro-porous membranes with large surface areas, have been successfully surface 
modified and various ligands tested for affinity purification purposes. In this project, 
we use an electrospun nanofiber membrane as the support material, allowing a higher 
 22





Figure 1.3 Protein A-G Gene Map 
A: IgG Binding Domain and Gene Map of Protein A 
B: IgG Binding Domain and Gene Map of Protein B 









1.2 Research Objectives and Approach 
 
The primary aim of this thesis research is to study the feasibility of applying 
electrospun regenerated cellulose affinity membrane for IgG purification. These 
affinity membranes are made up of a non-woven mesh of electrospun nanofibers, 
possessing several advantages over the conventional non-woven filter media. 
Properties like high porosity, high interconnectivity of the interstitial space and 
micro-scaled pore size are required for an ideal affinity membrane. Fibers with 
nano-scaled diameter are better in these areas than those fibers with typical diameters 
of several microns.  
The nanofibers were prepared using an electrospinning method from an electrically 
charged jet of polymer solution or polymer melt. Simple setup includes a pipette to 
hold the polymer solution, two electrodes and a DC voltage supply in the kV range. A 
high voltage (25kV) was applied between a needle and the collector plate, dropping 
the polymer solution from the tip of the pipette into fibers as the polymer solution is 
ejected. The jet is electrically charged and the charge causes the fibers to bend in such 
a way that every time the polymer fiber looped, its diameter was reduced.  
Recombinant protein A/G was then immobilized onto membranes as the ligand. 
[Figure 1.4] The adsorption of human IgG on stacked affinity membranes was studied. 
By adjusting several parameters, such as physical properties (pore sizes of membranes, 
tensile strength of the membrane etc.) and testing under different operation conditions 
(feed flow rate, incubation time and the effect of surfactant etc), the membranes were 
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characterized and evaluated for their purification effects. The strategy and solution 
concentration were optimized. Membrane surface morphology was studied using 
Scanning Electron Microscopy (SEM). Mechanical properties were measured by a 
tensile strength test.  X-ray Photoelectron Spectroscopy (XPS) and FTIR test were 
carried out for functional group analysis on the polymer surfaces. A bicinchoninic 
acid (BCA) assay evaluated the concentrations of the activated sites after protein A/G 
coupling and a UV spectrometer detected IgG binding efficiency. Finally, Sodium 
Dodecyl Sulfate Polyacrylamide Gel Electrophoresis （SDS-PAGE） and silver 
staining verified the purity of the refined IgG.   
 
 
Figure 1.4 Bio-Specific binding between ligand immobilized membrane and ligate IgG 







A flowchart of the whole experiment procedures of this work is on show in Figure 1.5 
 
Figure 1.5 A flowchart of the whole experiment procedures in this work 
Replotted from My Presentation PPT 
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Chapter 2 Literature Review 
2.1 Overview 
Monoclonal antibodies have a wide range of potential applications in 
immunodiagnostics (Siles-Lucas and Gottstein 2001) and immunotherapy(Orlandi 
1993). Recently, recombinant monoclonal antibodies have continued to increase in 
importance as therapeutics for the treatment of cancer and other diseases (Glassy and 
Dillman 1988; Matthey, Engert et al. 2000) dominating today’s biopharmaceutical 
pipeline (Fahrner, Knudsen et al. 2001; Siegel 2002; Zhou and Tressel 2006). Large 
scale production of these therapeutic molecules remains a challenge, however, as it 
requires a combination of high yield and reliability, and extremely pure product. 
Current strategies for the production of therapeutic monoclonal antibodies include the 
use of mammalian cell systems to produce recombinant antibodies (Abs) derived from 
mice bearing human Immunoglobulin trans-genes [Figure 2.1], humanization of 
rodent Abs, or phage libraries(van Dijk and van de Winkel 2001). This method of 
production enhances the need for the development of further efficient methods for 











Figure 2.1 Using mice that bearing human immune system genes within their genomes 
Replotted from http://energycommerce.house.gov 
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Perfusion chromatography and membrane chromatography are two alternatives to 
conventional gel bead chromatography-both developed in recent years. Many affinity 
ligands immobilized on beads are commercially available and this availability makes 
gel bead chromatography rather popular. Unfortunately, the commonly used soft gels 
suffer from some drawbacks for large-scale application in column chromatography. 
They have slower loading flow rate, worse compressibility and more pore diffusion 
(Coffinier and Vijayalakshmi 2004).  
Accordingly, the idea of using micro-porous membranes as support matrices has been 
developed and implemented over the past decades. Adsorptive membrane 
chromatography combines the technological advances in both membrane filtration 
and fixed-bed liquid chromatography. Affinity membranes fundamentally consist of 
micro-filtration membranes, to which specific selective-affinity ligands are attached. 
A configuration in which the feed solution flows provides a very short, wide bed; thus, 
high velocities and very short residence times are attainable with modest 
trans-membrane pressure drops. This configuration allows high flow rates to be 
achieved at low pressures, enabling short processing time for large protein volumes. 
Elimination of diffusion resistance usually leaves a system controlled by much faster 
binding kinetics, thereby facilitating adsorptive separation of proteins, typically, 
one-tenth the time common for packed columns (Birkenmeier and Dietze 1997; van 
Sommeren, Machielsen et al. 1997; Charcosset 1998).Adsorptive membranes exhibit 
high binding capacities, similar in magnitude to packed columns and by using 
stepwise elution, proteins can rapidly be concentrated 10-fold or more with 85-100% 
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recovery. Analytical separations of proteins equivalent to those of column 
chromatography are reached by using sufficient numbers of membrane stacks and 
gradient elution methods. The linear scalability of the membrane systems further adds 
to the attractiveness of the technology. Affinity membranes operated in convective 
mode can significantly reduce diffusion limitations commonly encountered in column 
chromatography.  
The use of membranes eliminates pore diffusion and reduces the mass transport 
resistance for the solute to the matrix. [Figure 2.2] Thus liquid diffusion to the 






Figure 2.2 Comparison of particle-& membrane-based chromatography 
Modified from Biotechnol. Prog. 1995, 11, 357-367 
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One of the most important factors in the development of membrane chromatography 
is the improvement of available membrane supports. Correct choice of membrane 
support and the covalent coupling between the micro-porous membrane and the 
ligand may be essential for the success of the desired chromatographic 
separation(Charcosset 1998). Current commercially available systems include flat 
sheet systems, membrane stacks, radial flow cartridges and hollow fiber modules. 
[Figure 2.3] These adsorptive membranes bear chemically reactive sites to which 
specific ligands can be covalently linked or they are supplied with specific ligands 
bound by the manufacturer. Our present work focuses on the application of nano-scale 
electrospun nanofiber membrane which is immobilized with protein A/G for the 
purpose of purifying human IgG.  
The structure of this review is as following: first, we introduce affinity 
chromatography method for large-scale antibody production. We will mainly describe 
the bio-specificity between human IgG and recombinant protein A/G. And then, we 
will introduce affinity membranes made by different labs and companies. Those 













Figure 2.3 Schematic comparisons of membrane-based adsorptions 
Arrows illustrate the direction(s) of bulk flow. Shading indicates membrane 
cross-sectional area which lies roughly perpendicular to bulk flow 
Modified from Journal of Chromatography A, 702 (1995) 3-26 
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2.2 Antibody Production and Purification 
2.2.1 Antibody Production 
Animals including human beings natural produce antibodies to protect against 
diseases. Vaccination and passive immunization extensively exploit this basic 
biological trait. The great variety of antibodies, as well as their high specificity and 
affinity for antigens (Ags), [Figure 2.4] also makes it possible to use these molecules 
actively for biomedical purposes other than passive protection against 
diseases(Houdebine 2002). As technology develops, the isolation and engineering of 
the corresponding genes is becoming less of a bottleneck in the process, which 




Figure 2.4 Illustrate Antibody-Antigen Binding  






Figure 2.5 The Antibody Downstream Process   
Reploted from a mini-review by(Tressel 2005) 
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According to different gene isolation resources, antibodies can be classified into three 
types: murine, chimerical (i.e. largely murine but containing the human constant 
region) or humanized. In the case of humanized antibodies, only the regions that 
recognize the antigen are not of human origin(Hudson 1998; Houdebine 2002). 
Ideally, the production system should provide antibodies requiring no modifications 
before use. The vast majority of monoclonal antibodies used to date are of murine 
origin. [Figure 2.6] Rabbits, which have a broad antibody repertoire, are a possible 
alternative of human antibody, but both of these approaches require antibody 
humanization(Huls, Heijnen et al. 1999). The most attractive strategy is to prepare 
human monoclonal antibodies; however, the cloning of the corresponding genes from 
human cells has proved to be difficult. Pioneering work showed that recombinant 
antibodies could be obtained from the blood of transgenic animals(Weidle, Lenz et al. 
1991). There are also many antibody expression systems(Houdebine 2002). For 
example, bacteria and yeast are only suitable for the synthesis of antibody fragments. 
By contrast, insect cells and Chinese hamster ovary (CHO) cells can be the source of 
intact antibodies fully capable of recognizing antigens(Andersen and Krummen 2002). 
Cultured cells, even when optimized, are expected to have limited capacity to produce 
large amounts of antibodies. Transgenic animals and plants appear to be the only tools 
enabling high production levels(Houdebine 2000). [Table 2.1] The expressed 
antibodies in the culture medium of expression cell systems may contain cell debris, 
lipids, DNA, cellular proteins, viruses and other pathogens and, potentially, serum 
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albumin, transferrin and serum. This raises the problem of antibody purification, a key 
stage in the preparation of biopharmaceuticals. 
 
Table 2.1 Antibody Expression Systems and Its Product 
Antibody Expression Systems Expression Products 
Bacteria and yeast Antibody fragments 
Insect cells and CHO cells Intact antibodies fully capable of recognizing antigens 
Cultured cells limited capacity to produce large amounts of antibodies 




Figure 2.6 Murine Origin Monoclonal Antibody Productions 
Reploted from http://webpages.marshall.edu/ 
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2.2.2 Antibody Purification 
There are several methods used for protein purification, such as gel filtration, ion 
exchange chromatography, high-resolution reversed-phase chromatography, and 
hydrophobic interaction chromatography, etc. [Figure 2.7] Among all the methods, 
affinity chromatography is the only method on the list that can separate or purify 

















Figure 2.7 Protein Purification Methods 
a) Column Chromatography b) Affinity chromatography  
c) Gel filtration d) Ion exchange chromatography 
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2.2.3 Affinity Chromatography 
Affinity chromatography is a more advanced powerful high-resolution separation 
technique for bio-molecules comparing to the column chromatography. It is based on 
highly specific and unique stereo-chemical interactions between bio-molecules rather 
than the unspecific charge interactions. In affinity chromatography, a ligand is 
covalently bound to a solid matrix which is packed into a chromatography column. A 
mixture of components is then applied to the column. The unbound contaminants, 
which have no affinity for the ligand, are washed through the column, leaving the 
desired component (protein, peptide, etc.) bound to the matrix [Figure 2.8] 
( Encyclopedia of Chromatography). Elution is accomplished by changing the pH 
and/or salt concentration or by applying organic solvents or a molecule which 


















Figure 2.8 The Process of Affinity Chromatography 







In recent years, the focus of affinity chromatography has shifted towards designing 
and selecting ligands of high affinity and specificity. [Figure 2.9] Ligands for protein 
affinity chromatography are distinguished into synthetic and biological. The 
ligand-specific affinity chromatography is based on the extremely specific selectivity 
of the immobilized ligand, directed towards the protein or antibody of interest. This 
mothod is particularly valuable for separations involving components of similar 
physical characteristics. 
Synthetic affinity ligands are generated either by de novo synthesis(Roque and Lowe 
2006) or modification of existing molecular structures (e.g. purine and pyrimidine 
derivatives, triazinyl nucleotide-mimetics, non-natural peptides, peptoids, and 
peptidomimetics, triazinyl dyes, and mimodyes, other triazinebased ligands, 
oligosaccharide, and boronic acid analogues). Biological ligands are obtained either 
from natural sources (e.g.RNA and DNA fragments, nucleotides, coenzymes, 
vitamins, lectins, antibodies, binding or receptor proteins) or in vitro from biological 
and genetic packages, employing display techniques(e.g. oligonucleotides, peptides, 
protein domains, and proteins). The main advantage of biological ligands (e.g. 
(oligo)-nucleotides, peptides, proteins, oligosaccharides) is their high selectivity and 
affinity. Such ligands can be generated from in vitro evolution approaches and 
selecting from large combinatorial ligand libraries based on biological/genetic 
packages. Synthetic ligands appear to tackle effectively most of the problems 
discussed above, possibly with the exception of reduced selectivity/affinity. 
Nevertheless, there are concerns regarding their toxicity and biocompatibility or at 
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least certain of their building blocks. Well-established chromatographic adsorbents 
with long industrial use, e.g. ion-exchange, hydrophobic and metal-chelating, bear 
defined, robust, and apparently nontoxic synthetic groups via which they interact with 
protein targets. However, experimental studies on the toxicity and other factors of 
synthetic affinity ligands and adsorbents are necessary(Clonis 2006). 
Although affinity chromatography is the most specific and effective protein 
purification technique, providing a rational basis for the purification of target proteins, 
however, it also has a reputation of being more expensive and less robust than other 
types of liquid chromatography. (Clonis 2006; Ravelet, Grosset et al. 2006) To date 
the technique has limited applicability for large-scale purification of pharmaceuticals. 
Fortunately, adsorptive membrane chromatography provides a solution to overcome 



















Figure 2.9 Different Kinds of Ligands 
a) amines b) Sulfhydryl c) Carbonyl Groups  
d) Carboxyl Groups e) Reactive Hydrogen  




2.2.4 Affinity Membrane Chromatography  
In membrane chromatography, the high specificity of affinity chromatography is due 
to the strong interaction between the ligand and proteins of interest. Membrane 
separation allows the processing of a large amount of sample in a relatively short time 
owing to its structure, which provides a system with rapid reaction kinetics(Unarska, 
Davies et al. 1990; Kashino 2003).The efficient recovery of labile bio-molecules 
requires rapid, reliable separation processes using mild conditions. Adsorptive 
membranes are available in a range of chemistries and geometries which permit their 
application as clarification, concentration, fractionation and purification tools in a 
bio-recovery sequence(D. Roper and E. Lightfoot 1995). 
 
Among all the protein purification technique, the selectivity and specificity in protein 
binding are based on electrostatic or ion-exchange, hydrophobic, and affinity 
interactions between the adsorbent surface and the protein surface. According to the  
different binding mechanisms, adsorptive membrane chromatography includes three 
types (Kawai, Saito et al. 2003). In affinity membrane chromatography, affinity 
interaction that is the interaction between bio-specific ligand and the target protein 
was employed to absorb the purified protein. The other popular method utilized 
ion-exchange membrane adsorption which use cation- or anion-exchange ligands. 
There are still other membranes which employed membrane adsorption by van der 










Figure 2.10 Forces Involved in Ab-Ag Binding 







Proteins dissolved in a buffer solution exhibit the characteristics of macromolecular 
ions depending on the pH of the solution. A protein behaves as positive or negative 
ion at a pH lower or higher than its isoelectric point (pI), respectively. Therefore, 
charged or ion-exchange materials have been used for protein purification.  
Moreover, a protein surface has various patches such as charged or non charged 
patches, and hydrophilic or hydrophobic patches. Hydrophobic interaction between 
proteins and the adsorptive materials is strengthened by the addition of high 
concentration of surfactant (Kawai, Saito et al. 2003). 
Adsorptive membranes consist of a substrate to which an interactive ligand is 
chemically coupled. Ideally, adsorptive membrane substrates are mechanically 
resilient and resistant to solvents used to activate coupling. They should not 
participate in secondary hydrophobic adsorption. Hydrophobic adsorption produces 
non-specific retention that interferes with product resolution and can also contribute 
to the denaturation of biopolymers. In D. Keith Roper’s review(D. Roper and E. 
Lightfoot 1995), Roper listed several polymeric and inorganic materials which 
constitute membrane substrates in different geometries, for example, cellulose(Qin, 
Wu et al. 2005), acrylic copolymers, poly (styrene-co- divinvylbenzene) matrix and 
Polyethylenimine (PEI)(Li and Spencer 1992). In addition to polymers, inorganic 
substrates (such as titanium) have been studied (Schwager 1998; Curnow, Bessette et 
al. 2005). Many of these materials are also widely used as membrane filters. 
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Affinity interaction or biologically specific interaction, such as a pair of antigen and 
antibody or enzyme and substrate, has been utilized for protein purification. In 
principle, the affinity interaction is most powerful when a target molecule is needs to 
be isolated from complex liquids by the smallest number of steps. The affinity 
interaction is ascribed to the integrated recognition of a molecule by the 
corresponding molecule based on size, electrostatic and hydrophobic interactions, 
metal-chelate and hydrgen bondings among others. Affinity ligands are classified into 
biospecific and pseudobiospecific ligands. The former ligands include monoclonal or 
polyclonal antibodies. The latter ligands include immobilized metals, hydrophobic 
amino acids, and dyes(Kawai, Saito et al. 2003). Affinity ligands are covalently 
attached to membrane matrices using coupling chemistries. Stable linkages are 
necessary to prohibit leaching of the ligand into the effluent stream. The length of 
spacer arm used is critical in the observed performance of affinity membrane systems. 
Capacity of affinity membranes for bio-molecules is in general lower than those 
observed in ion exchange or reversed-phase systems. An estimated one to two percent 
of potential affinity sites actually binds ligate. Observed multipoint attachment of 
ligand and ligate also limits binding capacity (Langlotz and Kroner 1992; D. Roper 
and E. Lightfoot 1995) Pseudo-biospecific ligands have been widely used in reported 
affinity-membrane adsorption. Examples include protein A, protein G, heparin, 
collagen, and two amino acids: arginine (Arg), and L-phenylalanine (Phe) coupled 
with an epoxide group. 
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Since our project targets immunoglobulin (IgG) for purification, we will mainly 
review immunoglobulin properties and purifications. The ligands and membranes 
used for IgG purification in affinity membrane purification chromatography will be 
further discussed.   
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2.3 IgG and It’s Binding Properties with Protein A/G 
2.3.1 Human Antibody 
Immunoglobulins, also known as antibodies, in human blood are substances produced  
by B-lymphocytes within the immune system in response to bacteria, viruses, or other 
foreign substances, such as fungus, animal dander, or cancer cells. Antibodies attach 
to the foreign substances, causing them to be destroyed by other immune system cells. 
Antibodies are usually specific to each type of foreign substance. For example, 
antibodies produced in response to a tuberculosis infection attach only to tuberculosis 
bacteria. Antibodies also play a role in allergic reactions. According to differences in 
their heavy chain constant domains, immunoglobulins are grouped into five classes, 
or isotypes: IgG, IgA, IgM, IgD, and IgE (as listed below). [Table 2.2] 
Table 2.2 Five Classes of Immunoglobulin 
 
Replotted from “Introduction to Antibodies” 2nd Edition CHEMICON@
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2.3.2 IgG properties and Purification 
The IgG immunoglobulin group consists of four protein subclasses all sharing the 
common structure as shown in [Figure 2.11] (IgG1, IgG2, IgG3 and IgG4), with IgG1 
being the largest fraction (~65%). The different subclasses vary slightly in chain 
composition, number and arrangement of their disulfide bonds and function. A IgG 
molecular is constructed of two heavy chains and two light chains. The two heavy 
chains which have a molecular weight of 50KD each and the two light chains which 
are 25KD each make up of the F(ab)2 region of IgG and can be recognized by 
different antigens. The specific binding region utilized for IgG purification is the Fc 
region which is at the C-terminal of heavy chains.  
 
Figure 2.11 The Structure of IgG  
Replotted from “Introduction to Antibodies” 2nd Edition CHEMICON@ 
 
IgG is routinely fractionated from large donor pools of normal plasma, where a broad 
spectrum of antibodies is available. Intravenous immunoglobulin G (IVIG) is 
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primarily used in the treatment of primary humoral immunodeficiencies and in the 
prevention and attenuation of infectious diseases(Li, Stewart et al. 2002; Boros, 
Gondolesi et al. 2005; Martin 2006). IgG is made by the human body and purified 
from pooled human plasma to IVIG. The manufacturing of the IgG molecule would 
usually damage its nature properties. Therefore, fractionators of IgG must strive to 
ensure that what is taken from a human body is exactly the same when it is returned to 
the human body for optimal tolerability and safety, both in terms of physiologic and 
pharmacologic parameters naturally represented in the human body. Given their 
fragile nature and large size (molecular weights of 35,000 to several hundred 
thousand), proteins are difficult to isolate and protein purification is technically 
demanding(Martin 2006).  
An effective strategy for isolating classes of proteins from large volumes of solution 
is to convert some proteins to precipitates while keeping other proteins in solution, e.g. 
the cold ethanol precipitation process(Zhang, Xie et al. 2005). What this method can 
not avoid, however, is the contaminants from other proteins. Thus, various attempts 
have been made to utilize chromatography(Lebing, Remington et al. 2003). 
Among the many chromatography methods, ion-change chromatography has been 
very successful in generating a rather high IgG recovery rate of 95%(Martin 2006). 
Affinity adsorption is the most selective technique for purification of plasma 
proteins(Nachman, Azad et al. 1992). Adsorptive membrane chromatography 
combines the selectivity of chromatography resins with the high productivity 
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associated of filtration membranes-all with a higher throughput and faster processing 
time than column chromatography. 
Micro porous membranes, with large surface area, were successfully developed by 
chemical modification or coupling with various ligands for affinity chromatography/ 
filtration purposes(M.A. 1996). 
 
2.3.3 Ligands for IgG Purification 
The conventional bio-specific ligands used to purify IgG from different sources are 
protein A and protein G ligands. These two proteins are capable of binding 
specifically to the Fc region of Igs and they are present on many staphylococcal and 
streptococcal strains. However, people also find that C-terminal domains of protein G 
have both IgG-Fc- and IgG-Fab-binding capacities(Eliasson, Andersson et al. 1991). 
Protein A is found on the surface of the majority of strains of Staphylococcus aureus, 
while protein G is expressed on the surface of most human group C and group G 
streptococci. Streptococcal protein G differs in its IgG-binding properties from the 
staphylococcal protein A(Sheoran and Holmes 1996). Protein A binds the human 
IgG1, IgG2, and IgG4 subclasses(Kronvall and Williams 1969), while protein G binds 
all four human IgG subclasses, including IgG3,(Bjorck and Kronvall 1984). It(Reis, 
Ayoub et al. 1984) have been shown that IgG from humans, rabbits, goats, mice and 
rats have higher avidity binding to protein G than protein A. It has also been shown 
that most of the determinants recognized by protein A and protein G on human and 
bovine IgG either coexist or closely overlap (Eliasson, Andersson et al. 1989).  By 
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using the acoustic waveguide device, Saha et al measured the IgG-protein G and 
IgG-protein A binding yielded apparent association constants of 3.29 x 104 and 8.02 x 
103 M-1 s-1 leading to equilibrium constants of 1.13 x 108 and 2.90 x 107 M-1, 
respectively (Saha, Bender et al. 2003). The measured apparent rate constants are 
consistent with literature reports of higher affinity of protein G for IgG.   
It is known that protein A has five IgG binding domains while Protein G has only 
three. In order to increase the binding property of the protein for IgG purification, 
researchers (Eliasson, Andersson et al. 1989) have constructed a recombinant protein 
named chimeric protein AG which combines the IgG binding domains of protein A 
and protein G. They revealed that the chimeric protein AG receptor has the combined 
binding properties of its parental receptors, protein A and protein G. At least with 
regard to human Ig, the chimera shows higher or equal avidity in comparison to the 










  IgG 3D 
Figure 2.12 IgG Binding Domain (Figures were produced by the software Protein Explorer) 
a) Schematic representation of SPG b) 3D model of IgG binding domain on SPG 
c) Gene code of IgG binding domain on SPG d) Schematic representation of SPA  
e) 3D model of IgG binding domain on SPA f) Gene code of IgG binding domain on SPG 










The Fc binding site is on the C-terminal of protein G and has 56 amino acids, and it 
binds to Fc region through hydrogen bonds and salt links by 12 charged and polar 
residues. [Figure 2.13] The Fc binding site of protein A and has 60 amino acids and it 
binds to Fc region through hydrophobic interactions by few polar contacts which are 5 
hydrophobic and 6 polar residues. [Figure 2.14]  
 
Figure 2.13 Specific Binding between Protein G & IgG 
(Figures were produced by the software Protein Explorer) 
 
Figure 2.14 Specific Binding between Protein A & IgG 
(Figures were produced by the software Protein Explorer) 
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Protein A, Protein G and chimeric protein AG are the most conventional ligands used 
for IgG purification. These bio-specific ligands are very specific as indicated by a 
good binding capacity. Amino acid LYS is the direct linkage made between ligands 
and ligates during the specific binding. [Figure 2.15].  
 
Reploted from My Presentation PPT 
 
Figure 2.15 The Process of Ligation and Coupling of LYS on Protein Surface 
(Figures were produced by the software Protein Explorer) 
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Protein A and G, as the most conventional ligands, have been extensively studied and 
used for IgG purification. They have high binding capacity with IgG and researchers 
have even developed many mimetics of Protein A for protein purification. (Li, Dowd 
et al. 1998) However, these conventional bio-affinity ligands have some 
disadvantages. The harsh elution conditions used (low pH), due to their high binding 
strength to the IgG, can compromise target stability and affect further processing. The 
drastic "clean in place" (CIP) and sanitation treatments could not be used due to the 
protein nature of ligand. Contamination, leakage of ligand and the decrease in ligand 
and hence the decrease of performance could occur after a few purification cycles. All 
these drawbacks led researchers to find alternatives to these bio-affinity ligands. 
Pseudo-biospecific affinity ligands such as metal chelates, immobilized histidine and 
thiophilic ligands have been proposed as alternatives. 
Currently, both protein A and protein G IgG purification kit are commercially 
available from many companies, indicating their popularity for IgG purification. In 
Zhou’s review paper (Zhou, J. X. and T. Tressel 2006), Zhou claimed that Protein A 
chromatography combined an excellent polishing process delivers a product-related 
purity of more than 99% — with most process impurities, including proteases, being 
washed away in the flow-through fraction. This also indicated that the design of 
proper affinity membranes for IgG purification is critical. We will therefore spend the 
next section reviewing affinity membrane/ligand combinations designed specifically 
for IgG purification. 
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2.4 Affinity membrane/ligand couplings for IgG purification 
Affinity membranes basically consist of micro-filtration membranes [Figure 2.16], to 
whose pores selective affinity ligands are attached(Leda R. Castilho 2002). They 
allow high flow rates to be achieved at low pressures, enabling the process whereby  
large volumes of dilute solutions can be applied to affinity membranes without any 
pretreatment(A. Malakian 1993) and without reducing the yield of the desired 
protein(Maurer 1998).  
The commonly used membranes include Nylon 66 coated with dextran or poly vinyl 
alcohol (PVA), as well as commercial pre-activated polysulfone and regenerated 
cellulose membranes. Leda et al (Leda R. Castilho 2002) compared ten different 
affinity membranes prepared by coupling various affinity ligands to different 
microfiltration membranes. Their results suggest that Zn-chelate and thiophilic 
membranes, beyond presenting rather low association constants (∼105M−1), had the 
disadvantage of needing a higher ionic strength to promote antibody adsorption. Also 
the histidine membrane presented an affinity too low for the intended application. The 
affinity membranes having peptide ligands and those based on dextran double-coated 
membranes also presented low association constants (∼105M−1) KA values of the 
PVA-Protein A and FD-Protein A, as well as of Ultrabind-Protein A and 








Figure 2.16 Different Principles of Size Exclusion Membrane and Affinity Membrane 




Ideal membrane substrates used for affinity membrane chromatography should fulfill 
the following conditions: (Zou, Luo et al. 2001) (1) proper pore structures and 
mechanical strength for use at high-flow rates and low back pressure, in rapid 
processing, (2) availability of reactive groups (such as –OH, –NH2, –SH, –COOH) for 
the further coupling of spacer arms or ligands, (3) chemical and physical stability 
under harsh conditions of high temperature or chemical sterilization, (4) a hydrophilic 
surface for higher recovery of protein activity. Based on different geometries, 
membranes are divided into four types: thin sheet, hollow fiber, spiral wound and 
cross-link rod. There are many commercially available materials to choose from, and 
they include organic, polymeric, inorganic, and composite materials. The most widely 
used organic materials fall into the following types: cellulose and its derivatives, 
polyamide and its derivatives, polysulfone and its derivative, polyethylene and 
polypropylene poly (GMA-co-EDMA) monoliths. In addition to polymers, inorganic 
materials have also been used as membrane substrates. For example, Li and 
Spencer(Spencer 1994) prepared an ion-exchange membrane with titanium dioxide. 
Serafica et al. (G.C. Serafica 1994) prepared immobilized-metal-chelate affinity 
membranes by using glass hollow-fiber microfiltration membranes as substrate. Here 
we mainly focus on the cellulose based membranes.  
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2.4.1 Cellulose-Based Membranes 
Cellulose is a polymer of glucose, with all of the glucose residues connected by ß-(1, 
4) linkages. Because this structure unit is stabilized by hydrogen bonds between the 
adjacent hexoses, cellulose forms a long straight polymer. Fibrils with high tensile 
strength can be formed by hydrogen binding between chains that are aligned together. 
(Drug Delivery: Principles for Drug Therapy by W. Mark Saltzman) 
 
Figure 2.17 Cellulose Structure 
Reploted from http://woodscience.oregonstate.edu/research.php 
The ion-exchange activity of residual carboxylic and aldehyde side groups in 
cellulose can be neutralized by borohydride reduction, and secondary hydrophobic 
interactions are reduced by the high level of hydration in these membranes. However, 
the application of native cellulose membranes to the purification of proteins is limited 
because their structure would be destroyed under alkaline condition. In addition, the 
number and ratio of the reactive groups (–CH2OH) in cellulose molecules are much 
lower than in agarose, and this results in a rather low ligand density of cellulose 
membrane (only 1% of the ligand density of agarose)(Zou, Luo et al. 2001). 
Regenerated cellulose and cellulose acetate membranes can be obtained through phase 
inversion. They present a hydrophilic surface and abundant reactive hydroxyl groups, 
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as well as low, non-specific protein absorption(Zeng and Ruckenstein 1999). Various 
ion-exchange groups such as sulfonic acid, quaternary ammonium, carboxyl, or 
diethylamine groups were coupled to crosslinked regenerated cellulose membranes. 
However, these membranes have small pores and a non-rigid structure resulting in 
poor mechanical strength. To overcome these shortcomings, several methods to build 
a support for these membranes have been proposed.  A method has been described 
by Guo et al (W. Guo 1994) for the preparation of cross-linked macro-porous 
cellulose membranes using coarse fibers as basic materials. Here(W. Guo 1994) filter 
paper was dispersed in a basic aqueous solution containing a certain amount of 
NaBH4. Then, the mixture was heated and kept boiling until a uniform pulp was 
obtained. The pulp was cast on a glass plate and frozen at −30 °C in a freezer for 45 
min. After it had thawed at room temperature, the plate was immersed in 10% HCl for 
1 h. The cellulose film was then rinsed with water until neutral, and was dried in air 
after being dipped in acetone for 2.5 h. Cross-linked cellulose membranes were 
prepared after the film had reacted with epoxy propane chloride at 50 °C for 3 h. 
These cross-linked membranes were chemically and mechanically more stable and 
acquired larger pore size. Macro-porous cellulose membranes can also indirectly 
obtained by deacetylating the cellulose acetate membranes with a methanolic KOH 
solution at room temperature for 6 h(A. Malakian 1993; N. Kubota 1996). These 
chemically modified membranes were hydrophilic and pliable and hardly swelled in 
various solvents. The pore sizes of these membranes ranged from 0.1 to 10 μm 
(mainly 3–5 μm). The hydroxyl groups on the cellulose surface were oxidized to 
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aldehyde groups, which provided sites for ligand coupling. These membranes can be 
used for IgG purification after coupling with the specific ligands such as Protein A ,G 
and AG.  
The semi-crystalline structure of cellulose provide cellulose rather good mechanical 
strength, however it  impedes the introduction of enough functional groups into 
cellulose, and this results in cellulose membranes having a lower adsorption capacity 
than agarose beads. Bead cellulose derivatives are one kind of commercially available 
bead-type cellulose. However this kind of cellulose has been reported that ligand 
density available on the surface of the modified cellulose is very small and displays a 
low adsorption capacity for proteins(Boeden, Pommerening et al. 1991). Composite 
cellulose has been made to overcome this shortcoming. Each monomer containing an 
active group in a polymer was covalently coupled to a few activated hydroxyl groups 
in cellulose. As a result, not only the ligand surface density on cellulose could be 
increased greatly, but also the composite matrix based on the half-rigid cellulose 
materials showed much greater strength. This permits fast flow of liquids through the 
composite membrane for the purpose of fast purifications.  
 
The composite cellulose membranes were prepared by grafting cellulose with acrylic 
polymers formed by polymerizing glycidyl methacrylate(Campos and Gushikem 1997; 
Jia, Yang et al. 1998; Zhou, Zou et al. 2000). By introducing epoxide groups to the 
membrane, this method can greatly improve the density of functional groups and 
increase the mechanical strength of the membrane (Zou, Luo et al. 2001). The epoxide 
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group density and the strength of the membrane were mainly affected by the 
polymerization and grafting reaction temperatures and times. Moreover, the character 
of the function groups derivatized on the surface of the cellulose also affects the 
strength of membrane. The strength of the membrane increases when it is coupled 
with hydrophilic groups, while it decreases with hydrophobic groups(Zou, Luo et al. 
2001). Composite cellulose membranes can also be prepared by treating original 
cellulose fibers and fibers with an alkaline solution(Zhou, Zou et al. 2000).  
Although alkali treatment of the cellulose fiber decreases the pressure resistance of 
the membrane to the mobile phases and greatly increases the volume accessible to the 
proteins, unfortunately it is unfortunately does not affect the immuno-adsorption 
capacity of human IgG on Protein A-immobilized membrane columns.  
 
2.4.2 Chitin and Chitosan Based Membranes 
Chitin and chitosan as the two cellulose derivatives have been used by researchers to 
prepare macro-porous membranes(Ruckenstein and Zeng 1998; X.F. Zeng and E. 
Ruckenstein 1999; Chen, Zheng et al. 2002; Shi, Zhang et al. 2005). Macro-porous 
membranes with chitin and chitosan have been reported to possess controlled pore 
sizes and good mechanical properties(Lozinsky, Plieva et al. 2001). Chitosan is the 
deacetylated product of chitin. Their structures are shown in [Figure 2.18]. They are 
good biological materials with easy availability, hydrophilicity, good biocompatibility, 
and chemical reactivity. Such properties make them excellent candidates not only in 
the area of drug delivery (Ishihara, Obara et al. 2006; Thongborisute, Tsuruta et al. 
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2006) and wound healing(Shi, Zhu et al. 2006) but also for macro-porous membrane 
for protein purification(Shi, Zhang et al. 2005).   
Macro-porous chitin membranes can easily be obtained indirectly via the acetylation 
of chitosan membranes with acetic anhydride in methanol solution at 50 °C for 1 h. 
The acetylated chitosan membranes have good chemical stability and mechanical 
properties. Chitin membranes are stable in both acidic and basic solutions, as well as 
in common organic solvents(Zeng and Ruckenstein 1999).  
 
 
Figure 2.18 Structures of Chitin and Chitosan 
Reploted from (Ruckenstein and Zeng 1998). 
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2.4.3 Other materials for affinity membranes 
Nylon is another kind of polymer used for affinity membrane. Nylon is a kind of 
polyamide derivative and it was designed to be a synthetic replacement for silk. The 
following picture shows one monomer of the diacid combined with one monomer of 
the diamine: 
 
Figure 2.19 Structure of Nylon 
Reploted from http://www.immnet.com/articles?article=1694 
 
Nylon has good mechanical properties and chemical stability and thus has gained 
wide acceptance in both laboratory and industrial use. Nylon membranes need to be 
hydrolyzed first to increase the number of active amino groups (NH2) and to avoid 
non-specific binding between proteins and membrane substrates during separation. 
These primary amino groups provide active sites for further coupling of spacer arms 
 69
or ligands. Covalent immobilization of Protein A within the porous matrix of a nylon 
Loprodyne membrane (Pall Bio Support, Portsmouth, UK) was achieved with 
modification of the 2-floro-1-methylpyridinium tolunene-4-sulphonate method. A 
commercially available nylon membrane was used by Birkenmeier and Dietze 
(Birkenmeier G 1993) to separate immunoglobulins from human plasma. Although 
the hydrophobic surface of nylon membranes is improved by hydrolysis and chemical 
modification, their applications, especially in the separation of some hydrophobic 
proteins, are still limited by their hydrophobic surface. Nylon membranes have a low 
concentration of terminal amino groups, and direct activation of the nylon matrix 
leads to low ligand densities. 
In addition to the cellulose-based membranes and the nylon-based membranes, other 
polymers such as Polyethersulphone (PES), PolyVinyliDene Fluoride (PVDF) etc 
have been employed for IgG purification. Since in our project we mainly use 
regenerated cellulose membrane for IgG purification, we will not go into details about 
other polymers. Here we only summarized membranes utilized for IgG purification 
and the corresponding ligands. See the following comparative table [Table 2.3] for an 
overview of membrane/ligand pairings.  
 70
Table 2.3 Affinity Membrane Used for IgG Purification 
Basic membranes Ligands Reference 
Modified Cellulose Protein G (Kochan J 1996) 
Cellulose Acetate Protein A/G (A. Malakian 1993) 
Cellulose/GMA composite Protein A/G (Zhou D 1998) 
Nylon Protein G (Sundaram and Inman 
1988; Mandenius and 
Ljunggren 1991;  
Petsch, Rantze et al. 1998)
Nylon Nonproteinogenous 
Ligand 
(Birkenmeier G 1993) 
PVDF Protein A (Rodemann K 1995) 
Modified polysufone Protein A (Klein E 1994) 
Modified poly(ethersufone)  Protein A (Charcosset C 1995) 
Poly(GMA-co-EDTA) Protein A (Josic D 1994) 
Poly(ether–urethane–urea) 
 Protein A (Bamford CH 1992) 
Poly(ethylene–co-vinylalcohol) Histidine (Bueno SMA 1995) 
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2.5 Market Information 
Because of the increasing number of biological therapeutics in clinical trials and the 
increase in researches focused on proteomics and genomics, the protein purification 
market is growing. Currently most labs are limited to simple and low yields 
purification could be processed and sample degradation remains a substantial problem. 
However, by the effort of advanced biomedical companies, several protein 
purification kits are now available on the market. (Shown in [Figure 2.20]) 
Among all those products, spin columns seem to be the most rapid and economical 
method to prepare a small amount of protein and most suitable for regular laboratory 
usage. The general application process of this spin column product type is shown in 
[Figure 2.21]. The common protein capturing capacity is approx. 0.2-0.3 mg per 
column (Vivapure Protein A Mini spin columns). Some of the commercialized 
membrane could provide a typical IgG binding capacity of 135 µg/cm2. the evaluating 
criterion has not be unified. The evaluation criteria between different companies have 
not been unified. 
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Figure.2.20 There are several kinds of protein purification products on the market 
Modified from Companies Websites 
Column www1.amershambiosciences.com SwellGel Discs Pierce www.piercenet.com 
Spin Column www1.qiagen.com Affinity Membrane www1.amershambiosciences.com 
Figure 2.21 The process of using spin column for protein purification 
Modified from Vivapure Corporation Website 
Colum SwellGel Discs 
Spin Membrane
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Chapter 3   Experiments 
3.1 Overview 
This chapter describes the materials, apparatus, and methods that were used in this 
work. Additional details regarding specific procedures are provided in the appropriate 
chapters. An overview of the whole procedures is given in [Figure 3.1]. 
 
Figure 3.1 An overview of the whole experimental procedures in this work. 
Electrospinning 
Cellulose Acetate (CA) Nanofiber Mesh 
Heat Treatment 
Alkaline Treatment 
Regenerated Cellulose (RC)  
Nanofiber Membrane 
Oxidation 
Protein A/G immobilized RC  
Nanofiber Affinity Membrane 
BSA Immobilization Test 
Immunoglobulin G Purification Test 
Binding Capacity Test Separation Efficiency Test 
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3.1.1 Materials 
Cellulose acetate(CA)(Mr=29,000,40%acetylgroups,Fluka);Human IgG (≥80% 
Sigma); Bovine Serum Albumin (BSA) (Sigma); ProteinA/G (ImmunoPure @, Pierce 
USA); Binding buffer (Pierce USA); Elution buffer (Pierce USA); Protein standard 
(@Kaleidoscope, @Prestain std broad range, BioRAD); Silver stain kit; (BioRAD); 
Sodium dodecyl sulfate (SDS)(10% ), Bromophenol blue, Coomassie Brilliant Blue 
G-250 (Merck), gel runing buffer were provided by NUMI NUS. 
3.1.2 Apparatus 
The surface morphology of fiber mesh was determined with light microscope and 
SEM. XPS (AXIS His-165 Ultra, Kratos Analytical, Shimadzu) was used to analyze 
the surface composition of the nanofiber. Attenuated Total Reflection Fourier 
Transform Infrared Spectroscopy （ATR-FTIR） spectra of the materials were 
obtained in a single-reflection mode on a Nicolet spectrometer system with an 
AvatarTM OMINI-SamplerTM accessory. Tensile test curve was obtained by a 
Instron Microtester 5848. The concentration of the protein was determined using a 
UV Spectrophotometer. SDS-PAGE electrophoresis was carried out with a Bio-Rad 
Electrophoresis System (MiniPROTEIN3 CELL 0.75mm, BioRAD). Photos of 
electrophoresis were taken using machine bought from Bio-Rad. Membrane appartus 
was purchased from (Qiagen, Germany) and phots of the electrophoresis result were 
taken by a digital camera. 
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3.2 Electrospinning of Cellulose Acetate Membrane 
All affinity experiments described in this thesis were performed using electrospun 
nanofiber membranes made in our lab. [Figure 3.2] illustrates the setup for the 
eletrospinning experiment. Polymer solution was stored in a syringe and pumped by a 
syringe pump at a set velocity through a metal needle. A high voltage was applied 
between the needle and the ground, forming an electrical force on the surface of the 
polymer solution at end of the needle to overcome the surface tension and produce an 
exceedingly thin charged jet. As the jet extended, the solvent evaporates, and the jet 
was drawn into fibers by the high voltage and deposited on the aluminum plate to give 
a nonwoven polymer nanofiber mesh. ( A. Frenot, I. S. C. (2003); Z.M. Huang 2003; 
















3.2.1 Sample Preparation for Electrospinning 
The first step of eletrospinning is polymer solution preparation. There could be many 
polymer concentrations and solvents available for a single polymer to be electrospun. 
The most appropriate concentration and solvent could be finally discovered after 
dozens of experiments. Cellulose acetate (CA) was dissolved in a mixture of organic 
solvent which might include acetone, Dimethylformamide （DMF）, Tri-fluor-ethanol 
（TFE） or the two of them as shown in [Table 3.1] Solution with different 
concentrations were prepared in order to obtain fine nanofiber and avoid polymer 
solution accumulation around the needle while the electrospinning was in process. 
The polymer solution was then stirred over night until the uniform and transparent 
solution was formed.  
 






Prescription Problem description 
Cellulose 
Acetate 
15.5% Acetone DMF TFE Acetone:DMF 
:TFE=3:1:1 















16% Acetone DMF Acetone:DMF 
=4:1 
Larger diameter fiber 
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3.2.2 Electrospinning Experiment Setup and Electrospinning Process 
The electrospinning experimental setup in [Figure 3.2] utilized in this experiment 
consisted of a syringe, blunt-end needles of different diameters, a flow meter, plastic 
tubing, aluminum foil, a flat collector plate, a high voltage source and a ground 
electrode.  
A syringe filled with CA polymer solution (10ml usual) was fixed on the platform of 
the syringe pump. The syringe pump flow meter was set at 4ml/hr. A positive voltage 
with a range of 20kV to 25kV was applied to the syringe needle (inner diameter of 
0.21 mm), which was positioned with 12cm between the needle tips and the collector 
plate. During electrospinning, nano-fibers were collected on a flat collector plate, 
which was covered with aluminum plate (10×10 cm). The aluminum plate was 
continuously moved to obtain a uniform mesh thickness. The collection time was set 
at 2 hrs to get a fiber mesh with a thickness of 0.01mm. System parameters chosen for 
electrospinning are listed below in [Table 3.2] to make it easy and clear for viewing. 
 









15.5% w/v 40-50% 12CM 20-25KV 4 ml/hr 2 hrs 
 
The electrospinning process is sensitive to humidity change in the spin hood(NC1 
2001). Singapore’s humidity is always between 85 and 95%. Therefore, it is much 
easier to spin beaded fiber which would affect not only the morphology but also the 
homogeneity and permeability of our membrane at such a high humidity, so a 
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dehumidifier machine (WDH-122HGD / WDH122HGD Dehumidifier, Widetech) 
was used continuously during the whole procedure of electrospinning, strictly 
controlling the humidity in the spin hood near 40%. 
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3.3 CA Membrane Regeneration and Surface Modification 
3.3.1 Heat Treatment 
After electrospinning, the electrospun CA nanofiber was carefully peeled off from the 
aluminum plate. It would then be sandwiched by two planes of PTFE plate, put into 
oven and heated. This process increases the membrane temperature from 25 oC to 210 
oC and maintains the 210 oC temperature for 1 hour. 
3.3.2 Alkali Treatment 
The heat-treated CA nanofiber mesh was then immersed into a 0.1M NaOH solution 
in water/ethanol (4:1) mixture for 24 hrs at room temperature. This step gave rise to a 
complete removal of the acetyl groups in the CA molecules via a hydrolysis reaction 
(H. Liu 2002; H. Liu 2003; W.K. Son 2004).The obtained regenerated cellulose (RC) 
nanofiber mesh was thoroughly rinsed in DI water to remove the organic solvent and  
other reagent. After that, the regenerated membranes were dried in a desiccator under 
vacuum. 
3.3.3 Activation of cellulose membrane by Sodium Periodate 
The deacetylated nanofiber mesh was then oxidized by 5% liquor sodium periodate 
(NaIO4), in order to produce dialdehyde cellulose. NaIO4 0.2g was dissolved in 40ml 
phosphate buffered saline (PBS) and the pH of the solution was adjusted to 9-10. 
Nanofiber mesh was immersed in liquor NaIO4.The reactions were carried out at 
room temperature in the dark for 3, 6, 9 and 12 hours, respectively. After that, the 
reaction was stopped by the addition of ethylene glycol. The oxidized membrane was 
then washed three times with PBS for three times. 
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The membranes are denoted as OXI3, OXI-6, OXI-9 and OXI12, respectively (the 
numbers are intended to indicate the time (hrs) of aldehyde to CA membrane). The 
change in mechanical properties of the fiber mesh was determined by the tensile test. 
BSA (Bovine serum albumin) as the module protein was employed to test the protein 
immobilization reaction on the dialdehyde cellulose membrane by using BCA™ 
Protein Assay Kit (Pierce) according to the protocol provided. 
3.3.4 BSA Immobilization Capacity of Activated Membrane 
A BSA protein solution with known concentration was prepared and used as the 
standard. Dialdehyde membrane oxidized for 3, 6, 9 and 12 hrs, were dunked in BSA 
solution for 6 hours, so that the BSA protein could be covalently bound to the 
membrane surface. Then the membrane was shaken in 1% Tween 20 solution in a 
shaking incubator at 37℃ overnight. Tween 20 is a surfactant which helps to 
eliminate nonspecific binding of the protein to polymer membrane surface. The 
amount of BSA binding on the membrane was determined by using BCA Protein 
Assay Kit (Pierce). The protein concentration detecting range of BCA assay is 
20-2,000 µg/ml. Cut OXI3, OXI-6, OXI-9 and OXI12 membrane were cut in to 5×5 
mm small pieces and put one piece of membrane placed into each well of a 
12-well-microplate for performing the BCA assay. Regenerated cellulose membrane 
without oxidation was used as a control. 0.1 ml of each standard replicate was 
pipetted into each appropriately labeled test well. 0.1 ml PBS was also pipetted into 
each well containing membrane slice. 2.0 ml of the WR (working reagent BCATM 
Kits, Pierce, USA) was then added to each tube and well mixed. The microplate was 
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covered and shaken at room temperature for two hours. The absorbance of the sample 
and standard wells were measured at 562 nm with the spectrophotometer, and the 
standard curve and the amount of BSA protein immobilized on the membrane 




3.4 Ligation: Covalent Binding of Protein A/G 
3.4.1 Spin Column Cartridge 
Two layers of round NaIO4 activated membrane sheets（DI=6mm，thickness＝10μm）
were packed in a spin column (illustrated in [Figure 3.3]). Under the membranes, 
there was a layer of macro porous support material and on the membrane there was a 





Figure 3.3 Scheme of Spin Column Cartridge used for Affinity Membrane. 
 
3.4.2 Ligation of Protein A/G 
Protein solution was added twice, 600 µl Protein A/G (1mg/ml PBS) was first added 
and when the first added protein solution traversed the membrane, another 600µl of 
protein A/G solution was also added. When the lower cavity was filled with solution, 
there was still some of the reaction solution left on the membrane. The membrane was 
immersed in the reacting solution (1 mg/ml protein A/G in PBS buffer) at 4℃, for 
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more than 12 hours. The membranes with immobilized protein A/G were then washed 
with 1% Tween 20 (Sigma) three times and immersed in PBS for further use. 
3.4.3 Protein A/G Binding Capacity Measurement  
The amount of protein A/G immobilized on the membrane was measured by the BCA 
Protein Assay Kit (Pierce, USA). The method of measurement was described in 
section 3.3.4 while BSA protein used for immobilization was replaced with protein 
A/G and the amount of protein A/G immobilized on the membrane was determined. 
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3.5 Spin Column Affinity Purification Experiment 
3.5.1 Experiment Preparation 
First, the protein A/G immobilized affinity membrane was packed into spinning 
column as shown in Figure 3.3. Human IgG (80% purity, Sigma) was dissolved in 
PBS and 500ul human IgG solution prepared with a concentration of 1mg/ml. PBS 
solution/binding buffer(1:1) was used for protein binding and elution buffer (Pierce, 
USA) was used for best recovery efficient.  
3.5.2 Long-Time Binding and Elution  
The long-time binding and elution procedures are performed in the following 4 steps: 
1. Equilibrate Protein A/G affinity membrane in the spin column by adding 1ml PBS 
solution and allowing the solution to drain through the membrane. Immerse the 
membrane for at least 5 minutes. 
2. Drop 500 μl prepared human IgG solution on the Protein A/G affinity membrane 
and allows it to flow completely through the membrane. The filtered Human IgG 
solution could be recollected and the above steps repeated. This process would be 
repeated three times which took about 45min to be completed. 
3. Incubate the protein A/G membrane in the human IgG solution for one or two hours, 
then remove IgG solution. 
4. Wash the affinity membrane with 500ul of elution Buffer, recollected and re-added 
that elution buffer onto membrane for three times and then freeze-dry the eluted 
protein solution in order to increase the concentration of Human IgG for better gel 
electrophoresis performance. Add 50ul PBS to the freeze-dried protein tube, then 
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shake and make protein dissolve completely. The purified antibodies could be used 
directly for SDS-PAGE gel. 
3.5.3 Short-Time Binding and Elution 
All short time binding and elution experiments were carried out at 4℃ which help to 
reduce protein denaturing. Centrifugation was carried out at 4°C, with a centrifugation 
speed of 1500rpm for 10 minutes.  
1. Equilibrate Protein A/G affinity membrane in the spin column by adding 1ml PBS 
solution /Binding buffer (1:1), allowing the solution to drain through the membrane. 
Immerse the membrane for at least 5 minutes. 
2. Apply 1ml of the human IgG solution onto the Protein A/G affinity membrane and 
incubates the protein A/G membrane in the human IgG solution for about 5mins for 
equilibration. 
3. Apply 500ul prepared human IgG solution onto the Protein A/G affinity membrane 
and allow it to flow completely through the membrane by low speed centrifugation (5 
min at 1500rpm 4°C).  
4. Recollect and re-add human IgG onto the membrane. This process will be repeated 
and will take about 15min for the whole process, before removing the IgG solution. 
5. Wash the Protein A/G membrane with 500ul of elution buffer, recollect and re-add 
that elution buffer onto the membrane. Repeat this step three times. 
6. Freeze-dry the eluted protein solution. Add 50ul PBS to the freeze-dried protein 
tube, then shake until protein dissolves completely. The purified antibodies can be 
used directly for SDS-PAGE gel. 
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3.6 Determination of IgG Binding Capacity 
The concentration of human IgG in the eluted protein solution was tested by BCA 
assay as described in section 3.3.4, in which regenerated cellulose membrane was 
replaced with protein A/G immobilized affinity membrane. The amount of IgG 
protein captured by protein A/G affinity membrane was then measured. The 
concentration of human IgG in the eluted protein solution was also detected by 
measuring the absorbance of the eluted protein solution at 280 nm using UV 
spectrophotometer.  
 
3.7 SDS PAGE for Determination of the Purity of Purified IgG 
Materials: 
Control: 1 mg/ml human IgG (80% Purity, Sigma) in PBS, 1mg/ml BSA (Sigma) in 
PBS, 1mg/ml Protein A/G (Pierce) in PBS, Protein Standard: KALEIDOSCOPE 
(BIORAD), PRESTAIN STD BROAD RANGE (BIORAD), Coomassie brilliant blue 
Equipments: 
Mini-PROTEAN® 3 Cell (BIORAD), Gel Doc 1000 Video Gel Documentation 
System (Bio-Rad Laboratories, Inc., Hercules, and CA) for taking photo of gel 
Working solution preparation: 
Stacking gel buffer （0.5 M Tris-HCl, pH 6.8） 
6 g Tris base  
60 ml deionized water  
Adjust to pH 6.8 with 6 N HCl. Bring total volume to 100 ml with deionized water 
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and store at 4 °C. 
Resolving buffer（1.5 M Tris-HCl, pH 8.8） 
27.23 g Tris base (18.15 g/100 ml) 
80 ml deionized water  
Adjust to pH 8.8 with 6 N HCl. Bring total volume to 150 ml with deionized water 
and store at 4 °C. 
Sample buffer (SDS Reducing Buffer)  
3.55 ml deionized water 
1.25 ml 0.5 M Tris-HCl, pH 6.8 
2.5 ml glycerol 
2.0 ml 10% (w/v) SDS 
0.2 ml 0.5%(w/v) bromophenol blue 
9.5 ml Total Volume 
Store at room temperature. Add 50 μl b-Mercaptoethanol to 950 μl sample buffer 
prior to use. Dilute the sample at least 1:2 with sample buffer and heat at 95 °C for 4 
minutes. 
Dye（Commassie brilliant blue G250 staining solution） 
Methanol, 50% Commassie Brilliant Blue R250, 0.05% 
Acetic acid, 10% DI water, 40% 
Washing solution 
Methanol, 50%  Acetic acid, 10% DI water, 40% 
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Human IgG at the concentration of 1mg/ml was added to the affinity membrane. After 
long time or short time binding and elution method (the specific procedure of elution 
can be found in section 3.5.2, 3.5.3), add 2 times of sample buffer into recollected and 
freeze-dried elution buffer, bore the sample tube at 95℃ for more than 4mins.  
4ml of the Acrylamide/Bis (30% T, 2.67% C, BIORAD) monomer and the initiator 
Ammonium Persulfate （APS 1mg/ml 10ul) were dissolved in distilled water (total 
volumn10 mL); Tetramethylethylenediamine （TEMED 5ul) was added to the 
mixture to initiate the polymerization. The polymerization process usually lasts for 
about 40 minutes. ［Table 3.3］ The pH of gel buffer systems, which influence the 





Table 3.3 Recipe for Preparing Working Solutions of SDS-PAGE 
 
Cited from Bio-Rad SDS-PAGE Manual 
 
 










Stocking  4% 6.1 1.3 2.5 0.1 
Resolving 12% 3.4 4.0 2.5 0.1 
 
*Resolving Gel Buffer - 1.5 M Tris-HCl, pH 8.8  
*Stacking Gels Buffer - 0.5 M Tris-HCl, pH 6.8 
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Apply 10 to 30 ul cold sample per well of gel. The protein sample was first run on 4% 
stacking gel at 80 volt for 30min and then run on 12% resolving gel continually at 180 
volt for about one hour. After the gel was running, the gel was stained with coomassie 
brilliant blue R250 and silver staining （Bio-Rad）, respectively. Gel images were 
acquired using Gel Doc 1000 Video Gel Documentation System (Bio-Rad 
Laboratories, Inc., Hercules, and CA) and a digital camera. 1 mg/ml human IgG (80% 
Purity, Sigma) in PBS, 1mg/ml BSA (Sigma) in PBS, 1mg/ml Protein A/G (Pierce) in 
PBS were used as control in the gel electrophoresis experiment. 
 
3.8 Membrane Morphology: Microscopic and SEM Observation 
The morphology of the fibrous membrane was observed under a light microscope and 
a SEM. Light microscopy observation helps to screen the uniformity of the fiber mesh 
during the procedure of electrospinning and help to avoid producing beads. Diameters 
of nanofiber mesh were controlled by adjusting electrospinning parameters and could 
be measured by SEM observation. 
 
3.9 Tensile Properties of the Single Layer Cellulose Membrane 
A tensile test was carried out to optimize oxidation time necessary to activate the 
nano-fiber membrane. For the mechanical strength test, the membranes were cut into 
strips with a dimension of 1×4 cm, and then mounted on an Instron Microtester 5848 
to obtain the tensile stress curve at a stretching speed of 10 mm/min. The mesh 
thickness was measured by a micrometer and the sample width (1 cm) was input into 
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the computer to calculate the tensile stress. 1 centimeter of fiber at each head was 
enhanced with hard crustaceous paper. (As show in [Figure 3.4]) 
 
Figure 3.4 Tensile Test Sample Preparations 
 
3.10 XPS and FTIR Tests for Membrane Surfaces Analysis 
The XPS (AXIS His-165 Ultra, Kratos Analytical, and Shimadzu) was used to 
analyze the element surface composition of the nanofiber. Fixed transmission mode 
was utilized with pass energy of 80 eV for the survey spectrum covering a binding 
energy from 0 to 1200 eV. Peak curve fitting was carried out using the software 
provided by the instrument manufacturer. Fourier transform infrared (FTIR) spectra 
were measured with an OMNIC FTIR spectrometer (International Scientific 
Instrument model DS 130). 
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Chapter 4 Results and Discussion 
4.1 Electrospinning 
A proper concentration of polymer was obtained according to microscopy analysis of 
fiber morphology and observation of the spin procedures. The recipe, which dissolved 
cellulose acetate CA (15.5% w/v) powder in acetone/DMF/TFE (trifluoroethylene) by 
ratio 3:1:1 could be used to obtain fine-diameter CA nanofibers and was most likely 
to avoid polymer solution accumulation around the needle while electrospinning. 
The morphology of fiber is presented in [Figure 4.1] which shows the randomly 
interconnected structure and smooth morphology of the nanofiber. The diameter of 
the nanofiber was in the range of 200–800 nm. 100 points from the picture of the 
fiber were measured by image analysis software (ImageJ, National Institutes of Health, 





Figure 4.1 SEM Images of Electrospun CA Nano-Fibers from CA/Acetone/DMF/TFE 
Solution (15.5 wt % CA)  
 
Figure 4.2 Calculating the Average Diameters of CA Nano-Fibers 
 (by software ImageJ) 
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Electrospun membrane with a thickness of around 60 μm was obtained through 2 hrs 
of electrospinning at 4ml/hr feed rate. The thickness of the CA nanofiber membrane 
was measured by a micrometer (Mitutoyo, Japan) and its apparent density and 






CA mass (g)CA apparent density (g/cm )
CA thickness(cm) CA area(cm )
CA apparent density(g/cm )CA porosity= 1- 100%
bulk density of CA(g/cm )
= ×
⎛ ⎞×⎜ ⎟⎝ ⎠
  
 
With the known bulk density of the CA (1.52 g/cm3), the porosity of the electrospun 
CA membrane can be calculated by measuring its apparent density, the results of 
which are summarized in [Table 4.1]. Porosity is an important parameter for affinity 
membrane. Membrane utilized for molecular separation and purification should be 
porous and strong enough to withstand the flow pressure, thus any membrane with 







Table 4.1 Calculation of the Porosity of Regenerated Cellulose Membrane 
Mass (g) Thickness (μm) Area (cm2) Apparent Density 
(g/cm3) 
Porosity % 










4.2 Heat Treatment 
Because the CA nanofibers did not adhere to each other, electrospun nanofiber mesh 
had a very poor tensile strength which significantly hindered the further surface 
modification and handling. Our approach to solving this problem was to use heat to 
fuse the nanofiber together by treating the nanofiber under a temperature close to but 
a little lower than its melting point. This treatment would not alter the morphology of 
the nanofibers as demonstrated in [Figure 4.5], where the SEM image showed that the 
heat-treated nanofiber still maintains its morphology as before the treatment. Before 
the heat treatment, however, these cotton-like membranes materials were flimsy and 
had low tensile strength. After heat treatment, those materials would obtain much 
better mechanical properties so as to facilitate usage during the experiments. [Table 
4.2] demonstrates a corresponding tensile test result which shows the obvious 
difference resulting from heat treatment. 
And for the following oxidation procedure, the nanofibers were sometimes observed 
to be even thinner which could be caused by dissolving of fiber surface during the 
reaction. By doing the experiment using our protocol, the morphology of fiber didn’t 
obviously change. But if experimental time for protein immobilization and capturing 
were too long, then the surface of nanofiber would not be smooth, as shown in [Figure 
4.5]. 
It is known that the glass transition temperature (Tg) of CA is 198–205◦C 
(Vaithiyalingam, Nutan et al. 2002) and the melting temperature (Tm) of CA is 
224–230◦C (Chauvelon, Doublier et al. 2003). Differential Scanning Calorimeter 
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(DSC) analysis of the CA nanofiber was carried out to screen its thermal behavior 
[Figure 4.4]. The Tg transition is not obvious at all in the DSC curve of the CA 
nanofiber, while a broad low endothermic peak centering at 220 ◦C can be found, 
corresponding to Tm. The strong broad absorption peak between 110 and 160 ◦C is 
the dehydration peak(Maria Silvia Bertran 2003) due to loss of water molecules which 
is strongly adsorbed in the material by hydrogen bonds. 
The heat treatment temperature of the material should be higher than Tg and lower 
than Tm. Therefore, different temperatures between 200◦C and 220◦C have been 
attempted and 210◦C was found to give excellent balance between tensile strength 
improvement and the heat endurance of the membrane material. [Figure 4.4] showed 
that after heat treatment, the CA fiber’s dehydration peak is significantly smaller, 
indicating that heat treatment released most of the adsorbed water molecules. 
 
Figure 4.4 DSC Curve of the (a) Untreated CA Nanofiber Membrane 
(b) Heat Treated CA Nanofiber Membrane 
(c) RC Nanofiber Membrane.  
Heating speed is 10℃/min.  







Figure 4.5 Nanofiber morphology after serials of treatment a) CA Membrane  
b) Oxidized c) Protein A/G immobilized nanofiber mesh 
 (d) Electrospun Nanofiber before Heat Treatment 










Figure 4.6 Tensile Test Curve of Membrane Differentiated by Duration of Oxidation 
 
 
















RA 20 10 0.055 0.55 0.922 0.0008 
OXI 3 20 10 0.055 0.55 1.908 0.0033 
OXI 6 20 10 0.07 0.7 2.026 0.0031 
OXI 9 20 10 0.062 0.62 1.159 0.0012 












Figure 4.7 (a) Molecular formula of CA, and 
(b) Molecular formula of regenerated cellulose after deacetylation 
Cited from “Polymer Data Handbook” 1999 Oxford University Press, Inc. 
 
As shown in previous work (Ung-Jin, S. K. 2002), electrospun CA fibers can be 
completely hydrolyzed by NaOH in an aqueous condition to obtain regenerated 
cellulose (RC).  In this work, complete hydrolysis was accomplished by 
deacetylating the electrospun CA fibrous membranes in 0.05 M NaOH/ethanol for 24 
h. The change in chemical structure of CA fibers during deacetylation was analyzed 
with FTIR spectroscopy. With increasing reaction time, the intensities of 
characteristic adsorption peaks attributed to the vibrations of the acetate group at 1745 
cm-1 (VC=O), 1375 cm-1 (VC-CH3), and 1235 cm-1 (VC-O-C) (Won Keun Son 
2003)decreased and finally disappeared [Figure 4.8]. On the contrary, an absorption 









Figure 4.8 Changes in FTIR Spectra with the Deacetylation  






Functional aldehyde group was introduced to the RC membrane surface by NaIO4 
oxidation. The chemical reaction for Dialdehyde cellulose (DAC) formation is shown 




Figure 4.9 Chemical Equation of RC Oxidation to form DAC 
FTIR spectrum data confirms the oxidation of regenerated cellulose membrane and 

















Figure 4.10 Changes in FTIR Spectra with Oxidation (a) Deacetylated Membrane (b) 




A longer reaction time would make the oxidation of fiber mesh more complete. 
However, at the same time, over reaction would worsen the mechanical properties of 
the fibers. A balance should be maintained in order to gain a high density of aldehyde 
groups of the fiber surface as well as obtaining good tensile strength of the fiber mesh. 
The amount of the aldehyde group on the oxidized cellulose fiber membrane was 
evaluated indirectly by a protein-binding ability test using bovine serum albumin as a 
model protein as shown in [Table 4.3]. The more aldehyde groups are on the 
membrane, the more BSA will be captured via amino reaction. The BSA amount was 
measured using the BCA assay. 
 
Table 4.3 Aldehyde Group on the Oxidized Cellulose Nanofiber Membrane 
Demonstrated by BSA Protein Coupled to Membrane Surface via Covalent Binding 
 
Oxidation hrs 0 3 6 9 12 15 




BSA binding capacity improved with increasing oxidation time, as shown in [Figure 
4.11]. The decrease in tensile strength was also studied using a tensile test. [Table 4.2] 
The BSA binding capacity of our membrane was tremendously increased as the time 
of reaction increased. However a visible decrease in mechanical property was 
observed between membranes treated for 6 hrs and those treated for 9hrs. Raising the 
















Figure 4.11 BSA immobilization curve at room temperature and under 50 ℃ 
 
CA-control is the membrane sample before heat treatment and oxidation. According 
to the graph obtained, the load our membrane could withstand increased about 4 times 
after heat treatment, and after 9 hrs oxidation, the membrane retains more than half its 
tensile strength. The optimal oxidization condition was found to be treating the 
membranes in 1% NaIO4 solution (pH=10~11) for 6 to 9 hrs. 
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4.5 Protein A/G Immobilization 
Protein A/G immobilized membrane were prepared for IgG purification. Protein A/G 
(1 mg/ml) solution was forced to flow through the oxidized RC membrane in the spin 
column twice by centrifuging it at 750-1000 rpm at 4°C for 10 minutes each time. The 
solution flowed through the membrane by centrifugal effect and was returned to the 
column whenever it had flowed through. After that, the membrane was incubated in 
the spin column which was filled with the protein A/G solution and left in the chiller 
at 4°C for 24 hours. It was then rinsed of residual protein solution by centrifuging 
(Eppendorf Centrifuge 5417C) it repeatedly with PBS. XPS experimental data which 
showed the appearance of N1s peak verified the presence of the Protein A/G on the 
membrane surface as shown in [Figure 4.12] 
 
 
Figure 4.12 XPS Spectra of (a) Oxidized Cellulose Nanofiber Membrane and 
(b) Protein A/G Immobilized Cellulose Nanofiber Membrane. 
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A bicinchoninic acid (BCA) protein assay kit (Pierce) was used to determine the 
amount of protein A/G covalently immobilized on the regenerated cellulose 
membranes. Circular pieces of membrane of known mass were added to 2ml of the 
working reagent (50:1 v/v, Reagent A:B) and 100 μl of different concentrations of 
protein A/G in PBS (0.1M, pH 7.4) of 0, 25, 125, 250,500,750,1000,2000 μg/ml were 
added to 2 ml of the working reagent. These samples were left at room temperature 
for 4 hours, after which the absorbance of the samples was measured at 562 nm. The 
calibration curve was plotted from the known Protein A/G concentrations and their 
absorbance at 562 nm. The Protein A/G density was determined from the curve. From 
BCA, 30ug Protein A/G per mg of membrane was obtained.  
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4.6 Capturing Capacity Test 
Once the protein A/G immobilized affinity membrane was prepared, the IgG 
capturing capacity of this membrane was to be measured, one of the key 
compatibilities to evaluate affinity membrane effectiveness. A layer of functionalized 
affinity membrane was equipped into spin column and made up a spin column 
cartridge as shown in figure 3.3. 500ul 1mg/ml IgG solution was injected into the 
cartridge and fully reacted with membrane for more than 6 hours at temeratures below 
4°C, and the membrane was then carefully flushed with PBS solution to wash off 
those dissociative proteins not adhering to membrane. IgG protein was eluted from 
membrane by add 500ul elution buffer, rinsed and re-injected several times. Then the 
concentration of IgG in the eluted sample buffer was measured by UV absorption at 
280nm.  
IgG concentration was determined by comparing the sample result with the 
calibration curve of BSA.A Protein-to-Protein Variation coefficient of 1.09 was 
considered. The total amount of IgG captured and eluted was 35ug IgG calculated by 
multiplying the protein concentration by (the binding capacity per spin well using a 
single layer of the membrane). The means a spin column containing a ten-layer stack 
of our membranes was able to capture 0.35mg IgG. The thickness of membrane layer 
was only about 0.6cm which left a lot of rooms for the sample solution. Our results 
compare favorably with commercial membrane products on the market. Vivapure 
Protein A Mini spin columns can purify 0.2-0.3 mg protein per spin column, for 
example. Our membrane has comparable protein capture ability. Dividing by the 
weight of that single layer membrane, the capturing capacity of our protein A/G 
immobilized affinity membrane is 18ug IgG/mg of membrane.  
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It was a theoretical possibility that protein A/G immobilized onto the membrane 
would be washed off with IgG during purification. SDS-PAGE results, however, 
showed neither the band of protein A/G neither nor its fragments. This result shows 
that the covalent bond between membrane and protein A/G is very strong, and the 
intermolecular force between protein A/G and IgG is several grades weaker. So the 
elution buffer could wash IgG off by weakening intermolecular forces but can not 
break those covalent bonds. 
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4.7 Separation Efficiency Test 
Separation efficiency capacity is another key item of compatibility to evaluate affinity 
membrane properties. It demonstrates whether our membrane can specifically capture 
IgG protein instead of merely than nonspecifically absorb all protein molecules in a 
protein mixture.  
A mixture of BSA (0.5 g/ml) and IgG (1 mg/ml) was applied to our membrane. Eluted 
solution was freeze-dried and resolved in PBS to obtain a 10-fold higher protein 
concentration. SDS-PAGE results [Figure. 4.13] revealed that the BSA protein as 
interfering component in the protein mixture wasn’t presented after membrane 
purification. This result demonstrated that the regenerated cellulose affinity 
membrane could specifically separate IgG protein from BSA and our RC membrane 
exhibits low non-specific protein binding. The result [Figure 4.14] of silver staining 
which was more sensitive at lower protein concentration reconfirmed the BSA 
removal and the recovery of IgG fragments.  
This satisfying separation efficiency result can be achieved mainly for three primary 
reasons. First, we chose regenerated cellulose polymer as our support material and its 
hydrophilicity reduces nonspecific absorption of proteins. Second, recombinant 
protein A/G is a very specific tool for IgG purification. The protein A/G molecule has 
six regions that specifically bind to IgG’s Fc, and the BSA binding domain was 
removed. During the coupling process, extensive amount of protein A/G was applied 
to cover reactive sites on the membrane surface after oxidation, so other proteins 
couldn’t be covalently coupled and were obstructed by protein A/G molecules. Last 
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but not least, while capturing protein a 1% surfactant Tween 20 was added and that 
helps to eliminate nonspecific binding of the protein to the polymer membrane 
surface.  
Figure 4.13: (a) SDS-PAGE Results of Unfiltered Sample （0.5g/ml BSA+1g/ml IgG） 
(b) SDS-PAGE Results of Unfiltered Sample （1g/ml BSA+1g/ml IgG）(c) Marker, (d) 
Condense the purified protein solution using freezing-dry and redissolving. 
 
 
Figure 4.14 Silver Staining Results  
(a) SDS-PAGE Results of Unfiltered Sample （0.5g/ml BSA+1g/ml IgG） 
 (b、c) SDS-PAGE Results of Purified Sample (d、e) Marker 
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Chapter 5 Conclusions and Recommendations 
5.1 Conclusions 
A novel electrospun nanofiber affinity membrane was investigated for application in 
protein IgG purification. Both fabrication and treatment of our membrane was fast 
and cheap. There are five main steps (eletrospinning, heat treatment, alkali treatment, 
oxidation, and protein immobilization) to prepare an affinity membrane. This 
membrane can be easy fabricated by eletrospinning technology and has a smooth 
morphology under SEM. The diameter of nanofiber varies from 200nm to 800nm and 
this yields the membrane with a relatively high surface-to-volume ratio. The porosity 
of the membrane reaches 82–85%. It facilitates the flowing of protein solution (a 
single pass with 500ul of protein solution can be finished in 10 minutes with the 
centrifugation speed set to 1500rpm) and makes the purification process faster 
without applying a very high pressure.  
By processing heat treatment and optimizing time for oxidation, our membrane 
obtained a good tensile strength of 3N/mm2, and can withstood experiment operation 
such as washing, drying, oscillation and nipping. The optimal oxidization condition 
was found to be treating the membrane in 1% NaIO4 solution (PH=10~11) for 6 to 9 




Protein A/G density on the protein A/G immobilized membrane was 30μg per mg of 
membrane. A 1mg/ml protein A/G solution was utilized for immobilization, and this 
high concentration helped to cover all reactive sites produced by oxidation on the 
membrane surface, making sure that all protein IgG was captured by the affinity 
membrane through specific binding between protein A/G and the Fc region of IgG, but 
not covalent binding. It increased the rate of protein recovery. 
Regenerated CA material is hydrophilic, offering a lower non-specific binding 
adsorption. SDS-PAGE and silver staining results indicated that the membrane 
exhibited very low non-specific adsorption as the main interfering impurity BSA band 
wasn’t observed after filtration. Other impurities present in the IgG samples were also 
not observed after filtration.  
A protein binding capacity of 18ug/mg membrane was obtained by using UV 
absorption of the eluted solution. And the protein binding capacity of a spin column 
filled up with single layer membrane was 35ug/column. So a spin column containing 
ten layers stack of our membranes is able to capture 0.35mg protein, and the thickness 
of membrane layer is only about 0.6cm which leaves significant space for the sample 
solution.  
Electrospun CA nanofiber affinity membrane is fabricated easily and cheaply, while 
being strong enough for large-scale production in industry. The regenerated CA 
material is hydrophilic, having very low non-specific protein binding capacity, hence 
offering good purity of recollected IgG. Compared to commercially available affinity 
membrane （Vivapure@ Protein a mini spin columns which can purify 0.2-0.3 mg 
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protein per spin column）, our membrane produces similar IgG capturing ability. So 




As for further study and application, there are two recommendations. 
First, it is easy to immobilize protein A/G onto membrane surface by covalent binding 
after membrane oxidation. But this random immobilization may occur at the 
IgG-binding sites of protein A/G, which consume the binding sites for IgG protein and 
reduce the IgG protein capturing capacity of our membrane.  To solve this problem, 
artificial ligands designed with an extra-large arm between the ligand molecule and 
the membrane surface can be utilitized for protein capturing purpose. It leaves the 
functional group of the ligand away from membrane surface to facilitate a capturing 
reaction. And as protein A/G is relatively costly, the use of artificial ligands will 
extensively reduce the cost. 
Another recommendation would be to optimize the design and protocol for spin 
column applications. Spinning column is a fast way to prepare for a small amount of 
protein sample. Since protein concentration in sample solution is usually very low and 
the volume of the spin column used in centrifugation could not be large, it is 
important to let the protein solution pass through membrane layers as many times as 
possible without losing protein during the operation. Thus, it would be nice to design 
a spin column which can be flipped over when a centrifugation is completed and then 
processed again, just like an hourglass.  
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